The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands

Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures

(2009) O. Sheehy et al.   OSTEOPOROSIS INTERNATIONAL

Excess mortality following hip fracture: a systematic epidemiological review

(2009) B. Abrahamsen et al.   OSTEOPOROSIS INTERNATIONAL

Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis

(2008) Fernie J. A. Penning-van Beest et al.   CURRENT MEDICAL RESEARCH AND OPINION

Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures

(2008) Willemijn M. Meijer et al.   CURRENT MEDICAL RESEARCH AND OPINION

Differences in persistence among different weekly oral bisphosphonate medications

(2008) O. Sheehy et al.   OSTEOPOROSIS INTERNATIONAL

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data

(2008) A. Cranney et al.   OSTEOPOROSIS INTERNATIONAL

Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

(2006) Carolyn M. Klotzbuecher et al.   JOURNAL OF BONE AND MINERAL RESEARCH